Relative roles of endothelin-1 and angiotensin II in experimental post-ischaemic acute renal failure

Nephrology Dialysis Transplantation

Volumn 19, Issue 1, 2004, Pages 83-94

  Jerkić, Mirjana ^a,b   Miloradović, Zoran ^b   Jovović, Durdica ^b   Mihailović Stanojević, Nevena ^b   Rivas Elena, Juan Vicente ^a   Nastić Mirić, Danica ^c   Grujić Adanja, Gordana ^c   Rodríguez Barbero, Alicia ^a   Marković Lipkovski, Jasmina ^d   Vojvodić, Srećko B ^d   Vicens Manero, Marta ^e   Pérez Prieto, Marta ^e   López Novoa, José Miguel ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c Inst of Nuclear Med Clinical Ctr   (Yugoslavia)

^d UNIVERSITY OF BELGRADE   (Serbia)

^e HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Acute renal failure; Bosentan; Ischaemia reperfusion injury; Losartan; Rats

Indexed keywords

ALKALINE PHOSPHATASE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BOSENTAN; DUP 153; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE; LOSARTAN;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BODY WEIGHT; CELL DAMAGE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; MALE; MEDICAL ASSESSMENT; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN FUNCTION; RAT; RECEPTOR BLOCKING; SURVIVAL; SURVIVAL RATE; TIME; TREATMENT OUTCOME;

ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; ENDOTHELIN-1; INFUSIONS, INTRAVENOUS; KIDNEY; KIDNEY FAILURE, ACUTE; LOSARTAN; MALE; MODELS, ANIMAL; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; RECEPTORS, ENDOTHELIN; REPERFUSION INJURY; SULFONAMIDES;

EID: 9144268319     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg521     Document Type: Article

References (23)

1. Lieberthal W. Biology of acute renal failure: therapeutic implications. Kidney Int 1997; 52: 1102-1115
2. Ishikawa I, Harris RC. Angiotensin actions in the kidney: renewed insights into the old hormone. Kidney Int 1991; 4: 583-596
3. Katoh T, Chang H, Uchida S, Okuda T, Kurokawa K. Direct effects of endothelin in the rat kidney. Am J Physiol 1990; 258: F397-F402
4. López-Farré A, Gómez-Garre DN, Bernabeu F, Montañés I, Millás I, López-Novoa JM. Renal effects and mesangial cell contraction induced by endothelin are mediated by PAF. Kidney Int 1991; 39: 624-630
5. Stein HJ, Lifschitz DM, Barnes BL. Current concepts on the pathophysiology of acute renal failure. Am J Physiol 1978; 234: F171-F181
6. 2-induced acute renal failure. Toxicol Appl Pharmacol 1998; 152: 315-326
7. Bird JE, Webb ML, Wasserman AJ, Liu ECK, Giancarli MR, Durham SK. Comparison of a novel ETA receptor antagonist and phosphoramidon in renal ischemia. Pharmacology 1995; 50: 9-23
8. Gellai M, Jugus M, Fletcher T, De Wolf R, Nambi P. Reversal of postischemic acute renal failure with a selective endothelin A receptor antagonist in the rat. J Clin Invest 1994; 93: 900-906
9. Kusumoto K, Kubo K, Kandori H et al. Effects of a new endothelin antagonist, TAK-044, on post-ischemic acute renal failure in rats. Life Sci 1994; 55: 301-310
10. Binet I, Wallnöfer A, Weber C, Jones R, Thiel G. Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A. Kidney Int 2000; 57: 224-231
11. Kontogiannis J, Burns KD. Role of AT1 angiotensin II receptors in renal ischemic injury. Am J Physiol 1998; 274: F79-F90
12. Sušicc D, Mandal AK, Kentera D. Heparin lowers the blood pressure in hypertensive rats. Hypertension 1982; 4: 681-685
13. Jerkic M, Varagic J, Jovovic D et al. L-Arginine reduces tubular cell injury in acute postischemic renal failure. Nephrol Dial Transplant 1999; 14: 1398-1407
14. Allred AJ, Chappell MC, Ferrario CM, Diz DI. Differential actions of renal ischemic injury on the intrarenal angiotensin system. Am J Physiol 2000; 279: F636-F645
15. Nishida M, Ieshima M, Konishi F, Yamashita J, Takaoka M, Matsumura Y. Role of endothelin B receptor in the pathogenesis of ischemic acute renal failure. J Cardiovasc Pharmacol 2002; 40: 586-593
16. Wilhelm SM, Simonson MS, Robinson AV, Stowe NT, Schulak JA. Endothelin up-regulation and localization following renal ischemia and reperfusion. Kidney Int 1999; 55: 1011-1018
17. Herrero I, Torras J, Riera M et al. Prevention of cold ischemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation. Nephrol Dial Transplant 1999; 14: 872-880
18. Gellai M, Jugus M, Fletcher T et al. Nonpeptide endothelin receptor antagonists. V: prevention and reversal of acute renal failure in the rat by SB 209670. J Pharmacol Exp Ther 1995; 275: 200-206
19. Huang C, Huang C, Hestin D et al. The effect of endothelin antagonist on renal ischaemia-reperfusion injury and the development of acute renal failure in the rat. Nephrol Dial Transplant 2002; 17: 1578-1585
20. Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG. Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol 2001; 281: H2337-H2365
21. Kim SJ, Lim YT, Kim BS et al. Mechanism of reduced GFR in rabbits with ischemic acute renal failure. Renal Fail 2000; 22: 129-141
22. Navar LG, Harrison-Bernard LM, Wang CT, Cervenka L, Mitchell KD. Concentrations and actions of intraluminal angiotensin II. J Am Soc Nephrol 1999; 10 [Suppl 11]: S189-S195
23. Richard V, Hogie M, Thuillez C. Angiotensin II receptor blockade unmasks a depressor response to endothelin antagonists in rats. Fund Clin Pharmacol 2000; 14: 101-106